Did this congressman benefit from a stock buy just before FDA approval?

On October 3, Representative Josh Gottheimer of New Jersey's 5th district disclosed a September 25 investment in Crinetics Pharmaceuticals (NASDAQ: CRNX), a mid-cap stock that no U.S. politician had previously traded. At that time, the CRNX share price was $50.58, and the representative's total purchase ranged from$1,001 to $15,000. Since then, CRNX stock has been on a sustained upward trend — at press time, trading at$56.48, an increase of 11.66% since Gottheimer's purchase. Depending on the amount inves ...